Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzymotec Ltd (NASDAQ:ENZY)

9.10
Delayed Data
As of Apr 21
 +0.15 / +1.68%
Today’s Change
5.20
Today|||52-Week Range
9.32
+38.93%
Year-to-Date
No recent news for Enzymotec Ltd.

Today’s Trading

Previous close8.95
Today’s open8.95
Day’s range8.95 - 9.10
Volume5,809
Average volume (3 months)27,014
Market cap$208.0M
Dividend yield--
Data as of 04/21/2017

Growth & Valuation

Earnings growth (last year)-143.33%
Earnings growth (this year)--
Earnings growth (next 5 years)+19.07%
Revenue growth (last year)-5.35%
P/E ratio--
Price/Sales3.12
Price/Book1.52

Competitors

 Today’s
change
Today’s
% change
CGENCompugen Ltd-0.08-1.86%
GNCAGenocea Biosciences ...0.000.00%
NVAXNovavax Inc+0.00+0.58%
FATEFate Therapeutics In...-0.05-1.08%
Data as of 04/21/2017

Financials

Next reporting dateMay 18, 2017
EPS forecast (this quarter)$0.06
Annual revenue (last year)$47.7M
Annual profit (last year)-$2.9M
Net profit margin-6.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Erez Israeli
Chief Financial Officer &
Vice President
Oren Bryan
Corporate headquarters
Migdal HaEmeq, Hazafon

Forecasts


Search for Jobs